Dec. 21-23 Regulatory Quick Takes: positive CHMP opinion for Pfizer-BioNTech COVID-19 vaccine; plus Urovant’s approval, a Feb. 9 adcomm for Keytruda in TNBC, NMPA reviewing a subcutaneous PD-L1, and more

By BioCentury Staff

Dec 22, 2020 | 1:04 AM GMT

Updated on Dec 23, 2020 at 8:34 PM GMT

CHMP recommends conditional approval of Pfizer-BioNTech COVID-19 vaccine
EMA’s

Continue reading with a
two-week free trial.

Regulation